| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Fenton Mary Kay serves as a Chief Financial Officer at CGEM. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $1.1M at current prices.
The biggest single holding is CGEM (~$1.1M) as Chief Financial Officer. The recent filings there lean toward selling, a net 4,398 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 4,398 | $13.62 | $59,900.76 | -3.4% | +2.4% | - |